KELLY RUIZ: Open Payments
NPI 1831758366 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 29 payments from 7 companies in 2025. Trend: 2023 $44 · 2024 $1,202 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $270 |
| AstraZeneca Pharmaceuticals LP | 2 | $160 |
| Phathom Pharmaceuticals, Inc. | 9 | $68 |
| Abbott Laboratories | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Optinose US, Inc. | 2 | $27 |
| PFIZER INC. | 1 | $20 |
Products named: AIRSUPRA, QULIPTA, UBRELVY, VOQUEZNA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Xhance, ELIQUIS.
Industry payments across CT — which companies pay providers there.
